AGI.do

Products

What will AGI do for Aminosalicylic acid?

This classification denotes an antitubercular agent with the molecular formula C7H7NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5B2658E0N2, chemically known as 6018-19-5 (monosodium, dihydrate) but generally known as aminosalicylic acid, which bears US NIH Compound Identifier 4649. European Medicines Agency schedules Aminosalicylic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12862MIG. World Health Organization schedules aminosalicylic acid in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, AMINOSALICYLIC ACID remains the US FDA Preferred Term for this commodity. Aminosalicylic acid bears US NLM identifiers UMLS ID C0030125 and NCI Concept Code C47394. SMILES: Oc1c(ccc(N)c1)C(=O)O.

How AGI delivers it

Four ways AGI delivers for Aminosalicylic acid

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Aminosalicylic acid, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Aminosalicylic acid, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Aminosalicylic acid connects

measured by

  • Assay Puritymodel
  • Chromatographic Impurity Profilemodel
  • Melting Pointmodel
  • Moisture Contentmodel
  • m-Aminophenol Contentmodel

Go deeper

Explore Aminosalicylic acid

Read the deeper take on agi.asView as markdown